With "Healthy China" elevated to a national strategy, Traditional Chinese Medicine (TCM), a treasure of Chinese civilization, has ushered in a golden age of inheritance and innovation. In this historical process, Houde Zukang Biopharmaceutical Co., Ltd. (hereinafter referred to as: Houde Zukang), leveraging its full-industry-chain layout, has deeply integrated the wisdom of TCM for millennia with modern technology, becoming a benchmark enterprise in the modernization of TCM. This comprehensive high-tech enterprise, integrating planting, R&D, production, and research-learning, is using a dual-drive model of "ancient formula, new research + technological empowerment" to provide a new paradigm for the breakthrough development of the TCM industry.

Seizing the Opportunities of the Times, Keeping Pace with the Innovation of the TCM Industry

Guided by the "Healthy China 2030" planning outline, the TCM industry has been given the important positioning of "national strategic resource." Government documents have repeatedly emphasized that "Traditional Chinese Medicine is a treasure of ancient Chinese science and the key to opening the treasure house of Chinese civilization." This statement has pointed the way for the modernization of TCM. According to authoritative data, the scale of China's TCM health industry has grown from 470 billion yuan in 2015 to nearly 1.5 trillion yuan in 2023, with a compound annual growth rate of 14.5%, becoming one of the most dynamic growth points in the health industry.

Facing the opportunities of the times, Houde Zukang was officially established in Qianjiang City, Hubei Province in 2019. Its predecessor can be traced back to Houde Zukang Biotechnology Co., Ltd., registered in Beijing in 2011. The company founder, Liu Huiwu, as a descendant of a TCM family, carries the mission of "promoting TCM culture and safeguarding the health of the Chinese people." He combines classic TCM formulas with modern biotechnology, aiming to build a complete TCM industry chain ecosystem. From winning the "China Independent Innovation Product" award in 2013 to listing on the Shanghai Equity Exchange Center in 2015; from investing in the construction of the Hubei R&D and production base in 2017 to changing its name to Hubei Houde Zukang Biopharmaceutical Co., Ltd. in 2020 and receiving the title of "Hubei Province Innovation and Quality Brand Double Commitment Unit," every step of the company's development has closely followed the pulse of the TCM industry upgrade.

From Source to End, Creating a Whole Industry Chain Layout

As the saying goes, "Good medicinal materials make good medicine." To ensure the efficacy of TCM materials, Houde Zukang has built its own 1,000-mu (approximately 67 hectares) TCM planting base in Shanglin County, Nanning, Guangxi, covering authentic native varieties such as dragon fruit and Dendrobium candidum. The base leverages the unique climate and soil conditions of the region, adopting a "multi-variety planting + ecosystem construction" model, upgrading from single-variety cultivation to a diversified planting system. This adherence to source quality lays a solid foundation for the entire industry chain.

In terms of R&D innovation, Houde Zukang holds high the fusion engine of ancient wisdom and modern technology. Over the past ten years, it has invested more than tens of millions of yuan in R&D and in 2023 established a research department by recruiting 12 R&D talents from Wuhan at high salaries. To date, it has successfully applied for 12 national invention patents in four categories, including herbal pastes, health foods, etc., with innovative achievements covering diverse fields such as dietary therapy, health care, and daily necessities. In December 2024, Houde Zukang passed the national high-tech enterprise certification, marking its innovative strength being recognized at the national level. More noteworthy is that the 8,000-square-meter R&D building has been topped out, with cutting-edge institutions such as a stem cell laboratory and an anti-aging center. The "Hundred Doctor Recruitment Plan" has also been launched simultaneously, continuously injecting high-end intellectual resources into R&D innovation.

The company's nearly 100-mu modern industrial base is also under construction. The first-phase production workshop covers 3,744 square meters, built strictly in accordance with national GMP standards, capable of producing over 100 types of products such as pastes, liquids, and tablets. The second-phase 13,000-square-meter smart factory is underway, integrating technologies such as the Internet of Things and intelligent monitoring, focusing on the intelligent manufacturing of disinfection products, medical devices, and special cosmetics, etc. It is expected that after commissioning at the end of 2025, it will form a 1 billion-level supply system. The 100,000-level GMP clean workshop deeply integrates traditional decoction techniques with modern pharmaceutical technology to ensure that product quality reaches internationally advanced levels.

In terms of brand and channel construction, Houde Zukang has built a three-dimensional operation system of "brand potential + channel momentum + user effectiveness." Through IP matrix building and user mind cultivation, it implements a digital brand strategy, establishing a service network covering 300+ cities and achieving a closed loop from precise marketing to user lifecycle management. At the same time, the eight product matrices are based on the TCM health philosophy of "clearing, regulating, adjusting, supplementing, and nourishing," providing modern people with systematic health solutions.

Exploring Breakthrough Paths for the Modernization of TCM, Continuously Contributing the Strength of Houde Zukang

Looking back at the development model of Houde Zukang, it has provided replicable breakthrough experience for the TCM industry: First, the dual-drive of cultural empowerment and technological innovation, adhering to the classic theories of "The Yellow Emperor's Inner Canon" and "Compendium of Materia Medica," while innovatively applying modern technologies such as biological extraction, nano-molecules, and low-temperature extraction, achieving a paradigm breakthrough of "ancient formula, new research." Second, the whole industry chain quality control system, standardized management of the entire chain from planting to sales, solves the pain point of insufficient standardization in the traditional TCM industry. Third, diversified scenario layout, products covering health management, beauty and skin care, chronic disease management, and other diversified scenarios, expanding the application boundaries of TCM.

The company's honor system also confirms its industry influence: from "China 3.15 Honest Brand," "Quality Reassurance National Standard Qualified Product" to "AAA Credit Enterprise," "Hubei R&D Base of Beijing Dietary Therapy and Pharmaceutical Medicine Research Institute," and "Key Promotion Unit of National Healthy Lifestyle Promotion Action," Houde Zukang has become a benchmark enterprise in the TCM health field. In 2021, its "liquid acupuncture" (Shentong antibacterial solution) project was included in the "National Promotion Project" of the Beijing Association for the Promotion of Chinese and Western Medicine Chronic Disease Prevention and Control, further demonstrating the social value of technological innovation.

It is reported that in July 2025, the Houde Zukang TCM Museum will be completed in Qianjiang. This 2,000-square-meter comprehensive exhibition hall, through more than 1,000 cultural relics, ancient books, and modern technological exhibits, systematically presents the development history of TCM, becoming an important platform for the enterprise to inherit culture and conduct science popularization education. This move marks Houde Zukang's deep extension from industrial operation to cultural inheritance, and also indicates its three future development directions:

First, deepen technological integration, relying on the R&D building and the doctoral team, to conduct cutting-edge research in stem cell technology and anti-aging fields, promoting the application innovation of TCM in precision medicine and chronic disease management; second, expand international layout, using the "Belt and Road" initiative to promote TCM culture and products to the international market and participate in global health governance; third, improve the health ecosystem, through the whole industry chain synergy of "planting + R&D + production + service," to build an integrated health service system covering prevention, treatment, and rehabilitation.
As the corporate culture interprets: "Upholding integrity for mutual benefit and common prosperity, carrying the world with great virtue; shouldering the mission without forgetting the original intention, for the health of the motherland." Guided by the Healthy China strategy, Houde Zukang, with a full industry chain layout as its pen and technological and cultural integration as its ink, is writing a new chapter in the modernization of TCM.